Danaher Stock News

Hamilton Point Investment Advisors LLC reduced its position in shares of Danaher Co. (NYSE:DHR) by 0.9% during the 3rd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 43,186 shares of the conglomerates stock after selling 387 shares during the quarter. Danaher comprises about 3.5% of Hamilton []

Hudson Valley Investment Advisors Inc. ADV lifted its holdings in Danaher Co. (NYSE:DHR) by 0.4% during the third quarter, according to its most recent Form 13F filing with the SEC. The firm owned 33,695 shares of the conglomerates stock after purchasing an additional 147 shares during the period. Danaher accounts for approximately 1.8% of Hudson []

Rosenbaum Jay D. cut its position in shares of Danaher Co. (NYSE:DHR) by 10.9% in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 3,872 shares of the conglomerates stock after selling 475 shares during the period. Danaher makes up about 2.0% of []

Related Stocks: DHR , W , ZI , ZM , DDOG , RBLX , ABNB , PINS , COIN , AMZN , SPOT , PYPL , ATVI , CRM , ZTS , ROP ,

Related Stocks: PSA , KEYS , WMT , VZ , PLUG , 8411 , HASI , SLB , DHR , WST , EXR , TMO , ESGD , SUSA , PBW , ICLN , ED , RF , BG , BLDP , TROW , TYL , 4503 ,

Relyea Zuckerberg Hanson LLC raised its holdings in shares of Danaher Co. (NYSE:DHR) by 23.3% in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 1,059 shares of the conglomerates stock after acquiring an additional 200 shares during the quarter. Relyea Zuckerberg Hanson LLCs []

Microscopy Market report provides an in-depth overview of Product Specification, technology, product type, and production analysis considering major factors such as Revenue, Cost, Gross, and Gross Margin. This study also analyzes the market status, market share, growth rate, future trends,

The Lab-on-a-chip Market covers the present scenario (with the base year being 2021) and the growth prospects of global Lab-on-a-chip market for 20212028. The report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by

Meridian Financial Partners LLC raised its stake in shares of Danaher Co. (NYSE:DHR) by 3.0% in the third quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 2,508 shares of the conglomerates stock after buying an additional 72 shares during the quarter. Meridian Financial Partners LLCs holdings []

Colonial River Wealth Management LLC acquired a new position in shares of Danaher Co. (NYSE:DHR) in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund acquired 7,330 shares of the conglomerates stock, valued at approximately $2,230,000. Danaher comprises about 1.6% of Colonial []

Danaher (DHR) closed the most recent trading day at $319.28, moving +0.32% from the previous trading session.

Immunohistochemistry Market 2021 Overview: With digital pathology and computational biology being the trend, strict control and validation methods are required to streamline operations. The way data is processed and evaluated may be further leveraged by artificial intelligence. This research report categorizes the

Optimum Investment Advisors cut its holdings in shares of Danaher Co. (NYSE:DHR) by 25.7% during the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 7,014 shares of the conglomerates stock after selling 2,420 shares during the period. Danaher comprises about 0.9% of Optimum []

Cadence Bank NA lowered its position in Danaher Co. (NYSE:DHR) by 0.8% during the third quarter, according to its most recent Form 13F filing with the SEC. The fund owned 6,021 shares of the conglomerates stock after selling 48 shares during the period. Cadence Bank NAs holdings in Danaher were worth $1,833,000 at the end []

The Operation Analytical robotics has been sure by the United States Food and Drug Management as a gadget to design, analyze, and control pharmaceutical manufacturing procedures finished the measurement of critical procedure limits which affect dangerous quality qualities. The global operation